查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1963632

迷走神經刺激市場：全球產業分析、規模、佔有率、成長、趨勢與預測（2025-2032）

Vagus Nerve Stimulation Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2025-2032
出版日期: | 出版商: Persistence Market Research | 英文 200 Pages | 商品交期: 2-5個工作天內

價格
簡介目錄

主要發現：

  • 迷走神經刺激市場規模（2025年預測）：5.423億美元
  • 預計市場規模（2032年）：10.134億美元
  • 全球市場成長率（2025年至2032年複合年成長率）：9.3%

迷走神經刺激市場研究範圍：

迷走神經刺激（VNS）是一種神經調控療法，透過向迷走神經傳遞電脈衝來調節神經和生理功能。 VNS 設備用於治療癲癇、憂鬱症和偏頭痛等疾病，尤其適用於對傳統治療方法反應不佳的患者。迷走神經刺激市場涵蓋了醫院和專科神經科中心使用的植入式和非侵入式設備。市場成長的促進因素包括神經系統疾病盛行率的上升、治療適應症的擴大以及神經調控設備的技術進步。

市場成長促進因素：

全球迷走神經刺激市場受多種關鍵因素驅動，包括癲癇、憂鬱症等神經系統疾病和慢性疾病的日益普遍。神經調控療法作為藥物治療的替代方案，其應用範圍不斷擴大，也推動了市場成長。技術進步，尤其是非侵入性刺激設備的進步，提高了患者的舒適度和治療的可及性。此外，不斷增加的研發投入和支持性的管理方案，正在加速創新迷走神經刺激解決方案的開發和應用。

市場限制：

儘管迷走神經刺激市場前景廣闊，但仍面臨許多挑戰，例如設備高成本以及部分地區認知度有限。植入式設備需要手術，這可能會阻礙部分患者的接受度。此外，對專業培訓和臨床經驗的需求也可能限制其廣泛應用。安全性、報銷政策和監管要求等方面的擔憂也可能成為市場擴張的障礙。

市場機會：

由於技術創新和臨床應用的不斷拓展，迷走神經刺激市場展現出巨大的成長潛力。非侵入式和穿戴式刺激器的研發為尋求手術替代方案的患者提供了新的治療選擇。針對中風復健和發炎性疾病等新治療領域的研究不斷深入，可望進一步擴大迷走神經刺激療法的應用範圍。策略合作、資金籌措舉措對神經調控研究投入的持續成長，都將有助於推動市場的長期發展。

本報告解答的關鍵問題：

  • 推動全球迷走神經刺激市場成長的關鍵因素是什麼？
  • 哪些設備類型和應用正在推動各種醫療保健機構的採用？
  • 科技進步如何改變迷走神經刺激市場的競爭格局？
  • 哪些主要企業參與者？它們正在採取哪些策略來維持其市場地位？
  • 全球迷走神經刺激市場有哪些新興趨勢與未來前景？

目錄

第1章執行摘要

第2章 市場概覽

  • 市場範圍和定義
  • 市場動態
    • 促進要素
    • 抑制因素
    • 機會
    • 主要趨勢
  • 宏觀經濟因素
  • 新冠疫情影響分析
  • 預測因子－相關性和影響

第3章 加值見解

  • 產品導入分析
  • 監管狀態
  • 價值鏈分析
  • 重大交易和合併
  • PESTLE分析
  • 波特五力分析

第4章 定價分析，2024年

  • 主要亮點
  • 影響產品價格的關鍵因素
  • 產品價格分析
  • 區域價格和產品偏好

第5章 全球迷走神經刺激市場展望

  • 主要亮點
    • 市場規模（單位）預測
    • 市場規模和年成長率
    • 絕對商機
  • 市場規模分析與預測
    • 2019年至2024年市場規模表現分析
    • 市場規模分析及預測（2025-2032年）
  • 全球迷走神經刺激市場展望：產品
    • 引言/主要發現
    • 2019-2024年按產品分類的市場規模、表現及銷售量（單位）分析
    • 市場規模及銷售量（單位）分析及預測（依產品分類），2025-2032 年
      • 植入式迷走神經刺激器
      • 外部非侵入式迷走神經刺激裝置
    • 產品市場吸引力分析
  • 全球迷走神經刺激（VNS）市場依應用領域展望
    • 引言/主要發現
    • 按應用領域分類的市場規模績效分析（2019-2024 年）
    • 按應用領域分類的市場規模分析與預測（2025-2032年）
      • 癲癇
      • 憂鬱症
      • 偏頭痛
      • 其他
    • 按應用領域進行市場吸引力分析
  • 全球迷走神經刺激市場展望：終端用戶
    • 引言/主要發現
    • 按最終用戶分類的市場規模績效分析，2019-2024 年
    • 依最終用戶分類的市場規模分析及預測（2025-2032 年）
      • 醫院
      • 專科診所
      • 門診手術中心
      • 學術和研究機構
      • 其他
    • 市場吸引力分析：最終用戶

6. 全球迷走神經刺激市場區域展望

  • 主要亮點
  • 2019年至2024年各地區市場規模表現分析
  • 市場規模分析及預測（依地區分類，2025-2032年）
    • 北美洲
    • 歐洲
    • 東亞
    • 南亞和大洋洲
    • 拉丁美洲
    • 中東和非洲
  • 按地區分類的市場吸引力分析

7. 北美迷走神經刺激市場展望

8. 歐洲迷走神經刺激市場展望

第9章 東亞迷走神經刺激市場展望

10. 南亞與大洋洲迷走神經刺激市場展望

11. 拉丁美洲迷走神經刺激市場展望

12. 中東與非洲迷走神經刺激市場展望

第13章 競爭格局

  • 2024年市佔率分析
  • 市場結構
    • 市場競爭強度分佈圖
    • 競爭對手儀錶板
  • 公司簡介（詳情 - 概述、財務狀況、策略、近期發展）
    • Soterix Medical Inc.
    • LivaNova PLC
    • SetPoint Medical
    • Vagutism
    • tVNS Technologies GmbH
    • electroCore, Inc.
    • Adriakaim, Inc.
    • MicroTransponder Inc.
    • Parasym, Ltd.
    • Pulsetto
    • Teliatry, Inc.
    • biolitec（R）Holding GmbH &Co KG
    • AURIMOD GMBH
    • Evren Technologies, Inc.
    • NeurGear
    • Hoolest
    • Neuvana
    • BioSelf Technology Ltd.

第14章附錄

簡介目錄
Product Code: PMRREP34750

Persistence Market Research has recently released a comprehensive report on the worldwide market for vagus nerve stimulation. The report offers a thorough assessment of crucial market dynamics, including drivers, trends, opportunities, and challenges, providing detailed insights into the market structure. This research publication presents exclusive data and statistics outlining the anticipated growth trajectory of the global vagus nerve stimulation market from 2025 to 2032.

Key Insights:

  • Vagus Nerve Stimulation Market Size (2025E): USD 542.3 Million
  • Projected Market Value (2032F): USD 1,013.4 Million
  • Global Market Growth Rate (CAGR 2025 to 2032): 9.3%

Vagus Nerve Stimulation Market - Report Scope:

Vagus nerve stimulation (VNS) is a neuromodulation therapy that involves delivering electrical impulses to the vagus nerve to regulate neurological and physiological functions. VNS devices are used in the treatment of conditions such as epilepsy, depression, and migraine, particularly in patients who do not respond adequately to conventional therapies. The vagus nerve stimulation market includes implantable and non-invasive devices used in hospitals and specialized neurology centers. Market growth is driven by increasing prevalence of neurological disorders, expanding therapeutic applications, and technological advancements in neuromodulation devices.

Market Growth Drivers:

The global vagus nerve stimulation market is propelled by several key factors, including the rising prevalence of neurological and chronic disorders such as epilepsy and depression. Increasing adoption of neuromodulation therapies as alternatives to pharmaceutical treatments has supported market growth. Technological advancements, particularly in non-invasive stimulation devices, have improved patient comfort and accessibility. In addition, growing research investments and supportive regulatory initiatives have accelerated the development and adoption of innovative vagus nerve stimulation solutions.

Market Restraints:

Despite promising growth prospects, the vagus nerve stimulation market faces challenges related to high device costs and limited awareness in certain regions. Implantable devices require surgical procedures, which may discourage adoption among some patients. In addition, the need for specialized training and clinical expertise can limit widespread use. Concerns regarding safety, reimbursement policies, and regulatory requirements may also create barriers to market expansion.

Market Opportunities:

The vagus nerve stimulation market presents significant growth opportunities driven by technological innovation and expanding clinical applications. The development of non-invasive and wearable stimulation devices offers new treatment options for patients seeking alternatives to surgery. Expanding research into new therapeutic areas, such as stroke rehabilitation and inflammatory diseases, is expected to broaden the scope of VNS therapy. Strategic collaborations, funding initiatives, and increased investment in neuromodulation research are likely to support long-term market growth.

Key Questions Answered in the Report:

  • What are the primary factors driving the growth of the vagus nerve stimulation market globally?
  • Which device types and applications are driving adoption across different healthcare settings?
  • How are technological advancements reshaping the competitive landscape of the vagus nerve stimulation market?
  • Who are the key players contributing to the vagus nerve stimulation market, and what strategies are they employing to maintain market relevance?
  • What are the emerging trends and future prospects in the global vagus nerve stimulation market?

Competitive Intelligence and Business Strategy:

Leading players in the global vagus nerve stimulation market focus on innovation, clinical research, and strategic partnerships to strengthen their market position. Companies invest in advanced neuromodulation technologies, including implantable and external stimulation devices, to improve therapeutic outcomes. Collaborations with research institutions and healthcare providers help expand clinical applications and accelerate product adoption. Continuous product development and regulatory approvals are expected to enhance competitiveness in the rapidly evolving neuromodulation landscape.

Key Companies Profiled:

  • LivaNova PLC
  • electroCore, Inc.
  • MicroTransponder Inc.
  • tVNS Technologies GmbH
  • SetPoint Medical
  • Parasym Ltd.
  • Soterix Medical Inc.
  • AURIMOD GmbH
  • Neuvana
  • Pulsetto
  • BioSelf Technology Ltd.

Vagus Nerve Stimulation Market Research Segmentation:

By Product:

  • Implantable VNS Devices
  • External Non-invasive VNS Devices

By Application:

  • Epilepsy
  • Depression
  • Migraine
  • Stroke Rehabilitation
  • Others

By End-User:

  • Hospitals
  • Specialty Clinics
  • Ambulatory Surgical Centers
  • Others

By Region:

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Table of Contents

1. Executive Summary

  • 1.1. Global Vagus Nerve Stimulation Market Snapshot, 2025 and 2032
  • 1.2. Market Opportunity Assessment, 2025-2032, US$ Mn
  • 1.3. Key Market Trends
  • 1.4. Future Market Projections
  • 1.5. Premium Market Insights
  • 1.6. Industry Developments and Key Market Events
  • 1.7. PMR Analysis and Recommendations

2. Market Overview

  • 2.1. Market Scope and Definition
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Opportunity
    • 2.2.4. Key Trends
  • 2.3. Macro-Economic Factors
    • 2.3.1. Global Sectorial Outlook
    • 2.3.2. Global GDP Growth Outlook
  • 2.4. COVID-19 Impact Analysis
  • 2.5. Forecast Factors - Relevance and Impact

3. Value Added Insights

  • 3.1. Product Adoption Analysis
  • 3.2. Regulatory Landscape
  • 3.3. Value Chain Analysis
  • 3.4. Key Deals and Mergers
  • 3.5. PESTLE Analysis
  • 3.6. Porter's Five Force Analysis

4. Price Analysis, 2024A

  • 4.1. Key Highlights
  • 4.2. Key Factors Impacting Product Prices
  • 4.3. Pricing Analysis, By Product
  • 4.4. Regional Prices and Product Preferences

5. Global Vagus Nerve Stimulation Market Outlook

  • 5.1. Key Highlights
    • 5.1.1. Market Volume (Units) Projections
    • 5.1.2. Market Size (US$ Mn) and Y-o-Y Growth
    • 5.1.3. Absolute $ Opportunity
  • 5.2. Market Size (US$ Mn) Analysis and Forecast
    • 5.2.1. Historical Market Size (US$ Mn) Analysis, 2019 - 2024
    • 5.2.2. Market Size (US$ Mn) Analysis and Forecast, 2025-2032
  • 5.3. Global Vagus Nerve Stimulation Market Outlook: Product
    • 5.3.1. Introduction / Key Findings
    • 5.3.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis, By Product, 2019 - 2024
    • 5.3.3. Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Product, 2025-2032
      • 5.3.3.1. Implantable VNS Device
      • 5.3.3.2. External Non-invasive VNS Device
    • 5.3.4. Market Attractiveness Analysis: Product
  • 5.4. Global Vagus Nerve Stimulation Market Outlook: Application
    • 5.4.1. Introduction / Key Findings
    • 5.4.2. Historical Market Size (US$ Mn) Analysis, By Application, 2019 - 2024
    • 5.4.3. Market Size (US$ Mn) Analysis and Forecast, By Application, 2025-2032
      • 5.4.3.1. Epilepsy
      • 5.4.3.2. Depression
      • 5.4.3.3. Migraine
      • 5.4.3.4. Others
    • 5.4.4. Market Attractiveness Analysis: Application
  • 5.5. Global Vagus Nerve Stimulation Market Outlook: End User
    • 5.5.1. Introduction / Key Findings
    • 5.5.2. Historical Market Size (US$ Mn) Analysis, By End User, 2019 - 2024
    • 5.5.3. Market Size (US$ Mn) Analysis and Forecast, By End User, 2025-2032
      • 5.5.3.1. Hospitals
      • 5.5.3.2. Specialty Clinics
      • 5.5.3.3. Ambulatory Surgical Centers
      • 5.5.3.4. Academic & Research Institutes
      • 5.5.3.5. Others
    • 5.5.4. Market Attractiveness Analysis: End User

6. Global Vagus Nerve Stimulation Market Outlook: Region

  • 6.1. Key Highlights
  • 6.2. Historical Market Size (US$ Mn) Analysis, By Region, 2019 - 2024
  • 6.3. Market Size (US$ Mn) Analysis and Forecast, By Region, 2025-2032
    • 6.3.1. North America
    • 6.3.2. Europe
    • 6.3.3. East Asia
    • 6.3.4. South Asia and Oceania
    • 6.3.5. Latin America
    • 6.3.6. Middle East & Africa
  • 6.4. Market Attractiveness Analysis: Region

7. North America Vagus Nerve Stimulation Market Outlook

  • 7.1. Key Highlights
  • 7.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019 - 2024
    • 7.2.1. By Country
    • 7.2.2. By Product
    • 7.2.3. By Application
    • 7.2.4. By End User
  • 7.3. Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
    • 7.3.1. U.S.
    • 7.3.2. Canada
  • 7.4. Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Product, 2025-2032
    • 7.4.1. Implantable VNS Device
    • 7.4.2. External Non-invasive VNS Device
  • 7.5. Market Size (US$ Mn) Analysis and Forecast, By Application, 2025-2032
    • 7.5.1. Epilepsy
    • 7.5.2. Depression
    • 7.5.3. Migraine
    • 7.5.4. Others
  • 7.6. Market Size (US$ Mn) Analysis and Forecast, By End User, 2025-2032
    • 7.6.1. Hospitals
    • 7.6.2. Specialty Clinics
    • 7.6.3. Ambulatory Surgical Centers
    • 7.6.4. Academic & Research Institutes
    • 7.6.5. Others
  • 7.7. Market Attractiveness Analysis

8. Europe Vagus Nerve Stimulation Market Outlook

  • 8.1. Key Highlights
  • 8.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019 - 2024
    • 8.2.1. By Country
    • 8.2.2. By Product
    • 8.2.3. By Application
    • 8.2.4. By End User
  • 8.3. Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
    • 8.3.1. Germany
    • 8.3.2. France
    • 8.3.3. U.K.
    • 8.3.4. Italy
    • 8.3.5. Spain
    • 8.3.6. Russia
    • 8.3.7. Turkey
    • 8.3.8. Rest of Europe
  • 8.4. Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Product, 2025-2032
    • 8.4.1. Implantable VNS Device
    • 8.4.2. External Non-invasive VNS Device
  • 8.5. Market Size (US$ Mn) Analysis and Forecast, By Application, 2025-2032
    • 8.5.1. Epilepsy
    • 8.5.2. Depression
    • 8.5.3. Migraine
    • 8.5.4. Others
  • 8.6. Market Size (US$ Mn) Analysis and Forecast, By End User, 2025-2032
    • 8.6.1. Hospitals
    • 8.6.2. Specialty Clinics
    • 8.6.3. Ambulatory Surgical Centers
    • 8.6.4. Academic & Research Institutes
    • 8.6.5. Others
  • 8.7. Market Attractiveness Analysis

9. East Asia Vagus Nerve Stimulation Market Outlook

  • 9.1. Key Highlights
  • 9.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019 - 2024
    • 9.2.1. By Country
    • 9.2.2. By Product
    • 9.2.3. By Application
    • 9.2.4. By End User
  • 9.3. Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
    • 9.3.1. China
    • 9.3.2. Japan
    • 9.3.3. South Korea
  • 9.4. Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Product, 2025-2032
    • 9.4.1. Implantable VNS Device
    • 9.4.2. External Non-invasive VNS Device
  • 9.5. Market Size (US$ Mn) Analysis and Forecast, By Application, 2025-2032
    • 9.5.1. Epilepsy
    • 9.5.2. Depression
    • 9.5.3. Migraine
    • 9.5.4. Others
  • 9.6. Market Size (US$ Mn) Analysis and Forecast, By End User, 2025-2032
    • 9.6.1. Hospitals
    • 9.6.2. Specialty Clinics
    • 9.6.3. Ambulatory Surgical Centers
    • 9.6.4. Academic & Research Institutes
    • 9.6.5. Others
  • 9.7. Market Attractiveness Analysis

10. South Asia & Oceania Vagus Nerve Stimulation Market Outlook

  • 10.1. Key Highlights
  • 10.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019 - 2024
    • 10.2.1. By Country
    • 10.2.2. By Product
    • 10.2.3. By Application
    • 10.2.4. By End User
  • 10.3. Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
    • 10.3.1. India
    • 10.3.2. Southeast Asia
    • 10.3.3. ANZ
    • 10.3.4. Rest of South Asia & Oceania
  • 10.4. Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Product, 2025-2032
    • 10.4.1. Implantable VNS Device
    • 10.4.2. External Non-invasive VNS Device
  • 10.5. Market Size (US$ Mn) Analysis and Forecast, By Application, 2025-2032
    • 10.5.1. Epilepsy
    • 10.5.2. Depression
    • 10.5.3. Migraine
    • 10.5.4. Others
  • 10.6. Market Size (US$ Mn) Analysis and Forecast, By End User, 2025-2032
    • 10.6.1. Hospitals
    • 10.6.2. Specialty Clinics
    • 10.6.3. Ambulatory Surgical Centers
    • 10.6.4. Academic & Research Institutes
    • 10.6.5. Others
  • 10.7. Market Attractiveness Analysis

11. Latin America Vagus Nerve Stimulation Market Outlook

  • 11.1. Key Highlights
  • 11.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019 - 2024
    • 11.2.1. By Country
    • 11.2.2. By Product
    • 11.2.3. By Application
    • 11.2.4. By End User
  • 11.3. Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
    • 11.3.1. Brazil
    • 11.3.2. Mexico
    • 11.3.3. Rest of Latin America
  • 11.4. Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Product, 2025-2032
    • 11.4.1. Implantable VNS Device
    • 11.4.2. External Non-invasive VNS Device
  • 11.5. Market Size (US$ Mn) Analysis and Forecast, By Application, 2025-2032
    • 11.5.1. Epilepsy
    • 11.5.2. Depression
    • 11.5.3. Migraine
    • 11.5.4. Others
  • 11.6. Market Size (US$ Mn) Analysis and Forecast, By End User, 2025-2032
    • 11.6.1. Hospitals
    • 11.6.2. Specialty Clinics
    • 11.6.3. Ambulatory Surgical Centers
    • 11.6.4. Academic & Research Institutes
    • 11.6.5. Others
  • 11.7. Market Attractiveness Analysis

12. Middle East & Africa Vagus Nerve Stimulation Market Outlook

  • 12.1. Key Highlights
  • 12.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019 - 2024
    • 12.2.1. By Country
    • 12.2.2. By Product
    • 12.2.3. By Application
    • 12.2.4. By End User
  • 12.3. Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
    • 12.3.1. GCC Countries
    • 12.3.2. Egypt
    • 12.3.3. South Africa
    • 12.3.4. Northern Africa
    • 12.3.5. Rest of Middle East & Africa
  • 12.4. Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Product, 2025-2032
    • 12.4.1. Implantable VNS Device
    • 12.4.2. External Non-invasive VNS Device
  • 12.5. Market Size (US$ Mn) Analysis and Forecast, By Application, 2025-2032
    • 12.5.1. Epilepsy
    • 12.5.2. Depression
    • 12.5.3. Migraine
    • 12.5.4. Others
  • 12.6. Market Size (US$ Mn) Analysis and Forecast, By End User, 2025-2032
    • 12.6.1. Hospitals
    • 12.6.2. Specialty Clinics
    • 12.6.3. Ambulatory Surgical Centers
    • 12.6.4. Academic & Research Institutes
    • 12.6.5. Others
  • 12.7. Market Attractiveness Analysis

13. Competition Landscape

  • 13.1. Market Share Analysis, 2024
  • 13.2. Market Structure
    • 13.2.1. Competition Intensity Mapping By Market
    • 13.2.2. Competition Dashboard
  • 13.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
    • 13.3.1. Soterix Medical Inc.
      • 13.3.1.1. Overview
      • 13.3.1.2. Segments and Product
      • 13.3.1.3. Key Financials
      • 13.3.1.4. Market Developments
      • 13.3.1.5. Market Strategy
    • 13.3.2. LivaNova PLC
    • 13.3.3. SetPoint Medical
    • 13.3.4. Vagutism
    • 13.3.5. tVNS Technologies GmbH
    • 13.3.6. electroCore, Inc.
    • 13.3.7. Adriakaim, Inc.
    • 13.3.8. MicroTransponder Inc.
    • 13.3.9. Parasym, Ltd.
    • 13.3.10. Pulsetto
    • 13.3.11. Teliatry, Inc.
    • 13.3.12. biolitec(R) Holding GmbH & Co KG
    • 13.3.13. AURIMOD GMBH
    • 13.3.14. Evren Technologies, Inc.
    • 13.3.15. NeurGear
    • 13.3.16. Hoolest
    • 13.3.17. Neuvana
    • 13.3.18. BioSelf Technology Ltd.

14. Appendix

  • 14.1. Research Methodology
  • 14.2. Research Assumptions
  • 14.3. Acronyms and Abbreviations